NYSE · Medical - Healthcare Plans
Oscar Health, Inc. (OSCR) Stock
$32.98
-0.36%
NYSE: OSCR
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
5 Insurance Stocks Poised to Outperform Q2 Earnings Expectations
Zacks · Jul 22, 2026
Oscar Health, Inc. (OSCR) Is a Trending Stock: Facts to Know Before Betting on It
Zacks · Jul 17, 2026
Why Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value Investors
Zacks · Jul 16, 2026
1 Russell 2000 Stock to Own for Decades and 2 We Avoid
StockStory · Jul 16, 2026
Zacks Industry Outlook Highlights Oscar Health, Radian, CNO Financial, Pelagos Insurance Capital and Horace Mann Educators
Zacks · Jul 16, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held5.38%
Institutions Held67.61%
Institutions Float Held71.45%
Peer Comparison
About Oscar Health, Inc.
Oscar Health, Inc. is led by CEO Mark Thomas Bertolini, employs 2,305 people, headquartered in New York City, US, publicly traded since 2021.
Oscar Health, Inc. (OSCR) stock trades at $32.98 with a market capitalization of $8.55B. The stock is valued at a price-to-earnings (P/E) ratio of 18.09, price-to-book of 4.56, price-to-sales of 0.52. Over the past 52 weeks the stock has ranged between $10.69 and $34.48, and currently trades 4.4% below its 52-week high.
On profitability, Oscar Health, Inc. generates a return on equity (ROE) of 38.53% — well above the market average, a sign of a high-quality business, return on capital employed of 24.60%, an operating margin of -3.38%, a net profit margin of 3.60%.